Skip to main navigation Skip to search Skip to main content

The dopamine D4 receptor activates intracellular platelet-derived growth factor receptor β to stimulate ERK1/2

  • Robin S. Gill
  • , Marilyn S. Hsiung
  • , Chi S. Sum
  • , Natalie Lavine
  • , Stewart D. Clark
  • , Hubert H.M. Van Tol
  • University of Toronto

Research output: Contribution to journal › Article › peer-review

18 Scopus citations

Abstract

Dopamine receptors are GPCRs that play important roles in locomotion, reward, and cognitive processes. Previously, we demonstrated that this receptor transactivates PDGFRβ to modulate ERK1/2 and NMDA receptor activity. Downregulation of maturely glycosylated PDGFRβ by prolonged exposure to PDGF-BB eliminated PDGF-BB-mediated ERK1/2 activation. The DRD4-mediated ERK1/2 response was only partially blunted by PDGF-BB-mediated downregulation, but remained sensitive to the PDGFRβ kinase inhibitor tyrphostin A9. Tunicamycin prevented the N-linked glycosylation and maturation of PDGFRβ as well as its activation by PDGF-BB. However, upon tunicamycin treatment, DRD4 continued to signal to ERK1/2 in a tyrphostin A9-sensitive manner. Collectively, our observations indicate that DRD4, unlike PDGF-BB, can activate a pool of intracellularly located PDGFRβ.

Original languageEnglish
Pages (from-to)285-290
Number of pages6
JournalCellular Signalling
Volume22
Issue number2
DOIs
StatePublished - Feb 2010

Keywords

  • Dopamine
  • G protein-coupled receptor
  • Platelet-derived growth factor
  • Transactivation

Fingerprint

Dive into the research topics of 'The dopamine D4 receptor activates intracellular platelet-derived growth factor receptor β to stimulate ERK1/2'. Together they form a unique fingerprint.

Cite this